NECTAR Everolimus Plus Cisplatin in Triple (-) Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
GDC-0941 and Cisplatin in Treating Patients With Androgen Receptor-Negative Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
cMet CAR RNA T Cells Targeting Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment
- Status
- COMPLETED
- Phase
- PHASE1
Tivozanib in Combination With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
An Open-Label Multicenter Phase 2 Window of Opportunity Study Evaluating Ganetespib in Women With Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase 1b Trial of Dinaciclib With Pembrolizumab for Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Phase 2 Study - Aurora + Angiogenic Kinase Inhibitor ENMD-2076 in Previously Treated Locally Advanced + Metastatic TNBC
- Status
- COMPLETED
- Phase
- PHASE2
Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of the Drug MM-151 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
- Status
- COMPLETED
- Phase
- PHASE1
Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
- Status
- COMPLETED
- Phase
- N/A
Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Adjuvant Platinum and Taxane in Triple-negative Breast Cancer (PATTERN)
- Status
- COMPLETED
- Phase
- PHASE3
Triple Negative Breast Cancer Biomarker Study
- Status
- COMPLETED
- Phase
- N/A
Study of Temsirolimus, Erlotinib and Cisplatin in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of NK012 in Patients With Advanced, Metastatic Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2